These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22410457)

  • 21. [Contemporary treatment of gastrointestinal stromal tumors].
    Nishida T
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1639-44. PubMed ID: 18931562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized therapy for breast cancer: a dream or a reality?
    Zardavas D; Pugliano L; Piccart M
    Future Oncol; 2013 Aug; 9(8):1105-19. PubMed ID: 23902243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Reaman GH; Sawaya R; Schilsky RL; Schuchter LM; Sweetenham JW; Vahdat LT; Winn RJ;
    J Clin Oncol; 2007 Jan; 25(1):146-62. PubMed ID: 17158528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized systemic treatment for breast cancer patients: is it a reality?
    Shimizu C; Fujiwara Y
    Breast Cancer; 2008; 15(2):141-4. PubMed ID: 18274835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder cancer: current management and opportunities for a personalized approach.
    Galsky MD; Hall SJ
    Mt Sinai J Med; 2010; 77(6):587-96. PubMed ID: 21105122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.
    Venkitaraman R
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):199-207. PubMed ID: 20131996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer management: opportunities and barriers to an individualized approach.
    Perez EA
    Oncologist; 2011; 16 Suppl 1():20-2. PubMed ID: 21278437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression-based diagnosis of efficacy of chemotherapy for breast cancer.
    Miki Y
    Breast Cancer; 2010 Apr; 17(2):97-102. PubMed ID: 20013078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of miRNA in the diagnosis and treatment of breast cancer.
    Castañeda CA; Agullo-Ortuño MT; Fresno Vara JA; Cortes-Funes H; Gomez HL; Ciruelos E
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1265-75. PubMed ID: 21916580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options.
    Voduc D; Nielsen TO
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S171-8. PubMed ID: 19158038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: latest advances towards an integrated approach.
    Vera-Ramirez L; Sanchez-Rovira P; Ramirez-Tortosa CL; Quiles JL; Ramirez-Tortosa MC; Alvarez JC; Fernandez-Navarro M; Lorente JA
    Cancer Treat Rev; 2010 Oct; 36(6):477-84. PubMed ID: 20299155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progress.
    Gridelli C
    Curr Opin Oncol; 2012 Mar; 24(2):115-6. PubMed ID: 22123236
    [No Abstract]   [Full Text] [Related]  

  • 34. Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease.
    Raut CP; Morgan JA; Ashley SW
    Curr Opin Gastroenterol; 2007 Mar; 23(2):149-58. PubMed ID: 17268243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing paradigms in breast cancer management: introducing molecular genetics into the treatment algorithm.
    Rayhanabad JA; Difronzo LA; Haigh PI; Romero L
    Am Surg; 2008 Oct; 74(10):887-90. PubMed ID: 18942607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis.
    Maldonado F; Jett JR
    Curr Opin Pulm Med; 2010 Jul; 16(4):315-20. PubMed ID: 20173641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic applications of gene expression signatures in breast cancer.
    Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
    Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic consequences of molecular biology advances in oncology].
    Bauvet F; Awada A; Gil T; Hendlisz A
    Bull Cancer; 2009 Jan; 96(1):59-71. PubMed ID: 19211361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.
    Miller WR; Larionov A; Renshaw L; Anderson TJ; Walker JR; Krause A; Sing T; Evans DB; Dixon JM
    J Clin Oncol; 2009 Mar; 27(9):1382-7. PubMed ID: 19224856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular subtyping of breast cancer: opportunities for new therapeutic approaches.
    Mullan PB; Millikan RC
    Cell Mol Life Sci; 2007 Dec; 64(24):3219-32. PubMed ID: 17957336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.